Verdonk Edward, Johnson Krystal, McGuinness Ryan, Leung Gordon, Chen Yen-Wen, Tang H Roger, Michelotti Julia M, Liu Vivian F
MDS Sciex, South San Francisco, CA 94080, USA.
Assay Drug Dev Technol. 2006 Oct;4(5):609-19. doi: 10.1089/adt.2006.4.609.
The CellKey (MDS Sciex, South San Francisco, CA) system enables comprehensive pharmacological evaluation of cell surface receptors, including G-protein coupled receptors (GPCRs) and tyrosine kinase receptors, using adherent and suspension cell lines and primary cells. A unique application enabled by the ability of the CellKey system to reliably quantify activation of endogenous receptors is receptor panning. This application allows investigators to easily screen disease-relevant cell types for functionally active target receptors by treating cells with a panel of receptor-specific ligands. Receptor panning of multiple cell types including Chinese hamster ovary, human embryonic kidney 293, HeLa, U-937, U-2 OS, and TE671 cells resulted in the identification of many functionally active, differently coupled endogenous GPCRs, some of which have not been previously documented in the literature. Upon detecting GPCR activation in live cells, unique cellular dielectric spectroscopy (CDS) response profiles are generated within minutes that reflect the signaling pathways utilized and have been shown to be characteristic of Gs, Gq, and Gi GPCRs. The fact that the CDS response profiles are predictive of the G-protein coupling mechanism of the receptor was demonstrated by using examples of subtype-selective agonists/antagonists to identify the subtypes of the endogenous histamine and beta-adrenergic receptors expressed in U-2 OS cells. A direct correlation is shown between receptor subtype G-protein coupling and CDS response profile. In addition, complex pharmacology, including detection of partial agonism and Schild analysis for endogenous receptors, is presented. The CellKey system allows investigators to conduct studies using endogenously expressed receptors to generate data that are physiologically relevant and in disease context.
CellKey(MDS Sciex,加利福尼亚州南旧金山)系统能够使用贴壁细胞系、悬浮细胞系和原代细胞对细胞表面受体进行全面的药理学评估,包括G蛋白偶联受体(GPCR)和酪氨酸激酶受体。CellKey系统可靠量化内源性受体激活的能力所带来的一个独特应用是受体淘选。该应用使研究人员能够通过用一组受体特异性配体处理细胞,轻松筛选与疾病相关的细胞类型,以寻找功能活跃的靶受体。对包括中国仓鼠卵巢细胞、人胚肾293细胞、HeLa细胞、U-937细胞、U-2 OS细胞和TE671细胞在内的多种细胞类型进行受体淘选,结果鉴定出许多功能活跃、偶联方式不同的内源性GPCR,其中一些此前尚未在文献中记载。在检测活细胞中的GPCR激活后,数分钟内即可生成独特的细胞介电谱(CDS)响应图谱,这些图谱反映了所利用的信号通路,并且已证明是Gs、Gq和Gi GPCR的特征。通过使用亚型选择性激动剂/拮抗剂的实例来鉴定U-2 OS细胞中表达的内源性组胺和β-肾上腺素能受体的亚型,证明了CDS响应图谱可预测受体的G蛋白偶联机制。受体亚型G蛋白偶联与CDS响应图谱之间呈现直接相关性。此外,还介绍了复杂的药理学,包括对内源性受体的部分激动作用检测和Schild分析。CellKey系统使研究人员能够使用内源性表达的受体进行研究,以生成与生理相关且处于疾病背景下的数据。